Pathogenica has developed new technology that unlocks the power of DNA sequencing.  By isolating only relevant genes in the sequence and analyzing them for specific pathogens and drug resistance, Pathogenica‚Äôs DxSeq platform is able to detect many diseases and different strains with extreme accuracy.  DxSeq extracts high resolution information from samples that enables breakthroughs in biosurveillance and clinical diagnoses that could deliver the promise of personalized medicine.  For more information, visit www.pathogenica.com.